Literature DB >> 6775593

Incidence of thymidine-dependent enterococci detected on Mueller-Hinton agar with low thymidine content.

R C Haltiner, P C Migneault, R G Robertson.   

Abstract

It was observed that 10% of urine culture isolates of enterococci tested for antimicrobial susceptibility failed to grow on commercially prepared Mueller-Hinton agar with low levels of thymidine and thymine. All strains could utilize exogenous thymidine and thymine and required only low levels (0.4-microgram disk) to support growth. All thymidine-thymine-requiring strains were resistant to trimethoprim-sulfamethoxazole.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775593      PMCID: PMC284006          DOI: 10.1128/AAC.18.3.365

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Thymine dependent strains of Escherichia coli selected by trimethoprim-sulphamethoxazole therapy.

Authors:  J W Tapsall; E Wilson; J Harper
Journal:  Pathology       Date:  1974-04       Impact factor: 5.306

2.  Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.

Authors:  J Barker; D Healing; J G Hutchison
Journal:  J Clin Pathol       Date:  1972-12       Impact factor: 3.411

3.  Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo.

Authors:  O A Okubadejo; R M Maskell
Journal:  J Gen Microbiol       Date:  1973-08

4.  Use of trimethoprim to obtain thymine-requiring mutants of Streptococcus faecalis.

Authors:  M H Andrew
Journal:  J Gen Microbiol       Date:  1973-01

5.  Letter: Is co-trimoxazole bactericidal in sputum?

Authors:  R W Lacey; E Lewis
Journal:  Br Med J       Date:  1973-10-20

6.  Letter: Thymine-requiring bacteria.

Authors:  L J Hayer; J Netherway
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

7.  Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1973-08

8.  Thymine-requiring bacteria associated with co-trimoxazole therapy.

Authors:  R Maskell; O A Okubadejo; R H Payne
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

9.  Human infections with thymine-requiring bacteria.

Authors:  R Maskell; O A Okubadejo; R H Payne; L Pead
Journal:  J Med Microbiol       Date:  1978-02       Impact factor: 2.472

10.  Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1972-06
View more
  5 in total

1.  Synergistic antimicrobial activities of folic acid antagonists and nucleoside analogs.

Authors:  Johannes Zander; Silke Besier; Hanns Ackermann; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

2.  Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.

Authors:  D J Hamilton; B K Ulness; L K Baugher; G W Counts
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

3.  Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.

Authors:  C H King; D M Shlaes; M J Dul
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

4.  Thymidylate Limitation Potentiates Cephalosporin Activity toward Enterococci via an Exopolysaccharide-Based Mechanism.

Authors:  Jessica S Hoff; Christopher J Kristich
Journal:  ACS Chem Biol       Date:  2016-03-23       Impact factor: 5.100

Review 5.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.